AmbioPharm: difference between revisions
Diff·revision 13 → 14·10:24, 10 Dec 2025
Difference between revision 13 and revision 14 of AmbioPharm. 2 lines changed; the page grew by 229 bytes.
| Revision 13 — 09:45, 4 Dec 2025 CheckSumChase (talk) add the minimum order quantity for custom synthesis 9,597 bytes +678 | Revision 14 — 10:24, 10 Dec 2025 Peptide_Pete (talk) add the registered legal name exactly as it appears in the registry record 9,826 bytes +229 | ||
|---|---|---|---|
| 58 | Reports on AMB material submitted to PeptidePedia between 2024 and 2026 cover the incretin analogues most heavily, with a smaller set on repair and secretagogue peptides and a handful on bulk raw material. Reported [[Area percent purity|area percent]] figures have been high across the set, and where a report and the accompanying certificate can be compared the two have generally agreed within a few tenths of a percentage point, with the certificate figure the lower of the two in the comparisons on file.{{r|reports}} | 58 | Reports on AMB material submitted to PeptidePedia between 2024 and 2026 cover the incretin analogues most heavily, with a smaller set on repair and secretagogue peptides and a handful on bulk raw material. Reported [[Area percent purity|area percent]] figures have been high across the set, and where a report and the accompanying certificate can be compared the two have generally agreed within a few tenths of a percentage point, with the certificate figure the lower of the two in the comparisons on file.{{r|reports}} |
| 59 | 59 | ||
| + | 60 | The submitted set covers a small number of the listed compounds. A reader should not read agreement on eight lines as a finding about three hundred and fifty; the unsubmitted lines are unmeasured rather than sound.{{r|reports}} | |
| + | 61 | ||
| 60 | == References == | 62 | == References == |
| 61 | {{reflist}} | 63 | {{reflist}} |